LOT Oriel Ltd
LOT Oriel Ltd
2 Projects, page 1 of 1
assignment_turned_in Project2007 - 2012Partners:LOT Oriel Ltd, XstalBio, Bruker Biospin Ltd, Merck Miilipore (UK), Astrazeneca +21 partnersLOT Oriel Ltd,XstalBio,Bruker Biospin Ltd,Merck Miilipore (UK),Astrazeneca,GlaxoSmithKline,Scottish Funding Council,University of Glasgow,Organon Research Scotland,CEM Microwave Technology Ltd,CEM Microwave Technology Ltd,University of Glasgow,XstalBio,AstraZeneca plc,SFC,MSC-Rigaku,University of Strathclyde,Bruker Corporation,LOT Oriel Ltd,Schering-Plough Research Inst - Newhouse,ASTRAZENECA UK LIMITED,MSC-Rigaku,University of Strathclyde,AstraZeneca UK Ltd (Loughborough),Merck Speciality Chemicals Ltd,GlaxoSmithKline R & D LtdFunder: UK Research and Innovation Project Code: EP/E036244/1Funder Contribution: 2,657,690 GBPThis application aims to catalyse and sustain a new dimension in UK research capability in physical organic chemistry. Our strategic alliance in physical organic chemistry will provide a unique continuum of expertise to tackle research opportunities in areas as diverse as materials chemistry, synthesis methodologies and pharmaceutical discovery and development. It will have the capability to address issues from solid-state to solution and gas-phase, from small molecules to biopolymers, and from nanoscale to pilot plant. We focus on topics of international significance to industry worldwide as well as to academic chemistry, that will help to (i) drive the creation of 21st-century electronic materials, devices and technologies (ii) understand and exploit methodologies for assisting chemical reactions with the potential to revolutionise energy use in chemicals and pharmaceuticals industries (iii) provide new and more effective medicines through understanding molecular recognition in pharmaceutical systems including drug-receptor, drug-drug and drug-carrier complexes. Its importance is underlined by the initial substantial support from diverse sectors of the chemicals and pharmaceuticals industry that we have so far put in place. It will initially lead to 26 new appointments, and we look forward to even more dynamic growth as the program unfolds.
more_vert assignment_turned_in Project2008 - 2018Partners:Birmingham City Council, Medilink West Midlands, Medilink East Midlands, University Hospitals Birmingham NHS Foundation Trust, Diamond Light Source +42 partnersBirmingham City Council,Medilink West Midlands,Medilink East Midlands,University Hospitals Birmingham NHS Foundation Trust,Diamond Light Source,Carl Zeiss Ltd,Jeol UK Ltd,University of Birmingham,Advantage West Midlands,Lambda Photometrics Ltd,Nikon UK Ltd,Thinktank Birmingham Science Museum,Central Technology Belt,Diamond Light Source,Nikon UK Ltd,QinetiQ,PerkinElmer Life and Analytical Sciences,Thinktank Birmingham Science Museum,Luminescence Services Ltd,Thinktank,HPLB,University Hospital NHS Trust,RENISHAW,University of Birmingham,Bruker Biospin Ltd,QinetiQ (Malvern),Lambda Photometrics Ltd,GE Healthcare,Smith & Nephew plc (UK),University Hospitals Birmingham NHS FT,LOT Oriel Ltd,Advantage West Midlands,Qioptiq Ltd,Birmingham City Council,Smith & Nephew (United Kingdom),Hewlett-Packard Ltd,Renishaw plc (UK),PERKINELMER LAS (UK) LIMITED,Jeol UK Ltd,Carl Zeiss Ltd (UK),Bruker Corporation,LOT Oriel Ltd,Luminescence Services Ltd,GE Aviation,Central Technology Belt,GE (General Electric Company) UK,Diameter LtdFunder: UK Research and Innovation Project Code: EP/F50053X/1Funder Contribution: 7,181,440 GBPThe PSIBS Doctoral Training Centre (DTC) will focus on the development of the physical sciences of imaging and the computational analysis of image data to address key problems in the biological and biomedical sciences.The importance of Imaging to Bioscience and Medicine has been highlighted both by the N111 and the UK research councils.There is art apparent and growing need for people with these skills within UK industries with diverse business focuses (proposal section 3). This is reflected by their involvement in this PSIBS DTC and their contributions to the training.Two key benefits of training cohorts of students rather than individually funded students are: (1) The PSIBS multi-disciplinary taught programme that will upgrade the skill- and knowledge-base of traditional UK bachelors-level single-discipline graduates to underpin and enable cross-disciplinary PhD research. (ii) The students will develop extensive and cross-disciplinary links and networks, both with other PSIBS students and the many PSIBS academics, which will persist throughout their future research careers.Imaging technology is evolving faster than the standard grant turnaround time and dynamic, responsive PhD research within a critical mass of experts will enable (a) rapid response and (b) cutting edge research against our overseas competitors (proposal section 4).
more_vert
